范乐宇表示，下一步，广东金融监管局将从以下三个方面持续引领广东银行业、保险业加快为大湾区新 质生产力发展赋能： 8月30日，广东金融监管局党委委员、副局长范乐宇在粤港澳大湾区金融发展论坛上表示，将全面加强 科技支行建设为抓手，给予更加灵活包容的监管政策，为探索提供适配科技型企业全生命周期的特色金 融产品打开政策空间。 范乐宇观察到，科技金融专营体制建设水平与大湾区国际科创中心建设需求不够匹配，科技金融服务专 业化、特色化、精准化仍显不足等问题。 范乐宇表示，需要以监管赋能、政策赋利，进一步推动做优、做强、做专科技支行，发挥引领示范作 用，渐次形成与新质生产力相适配的具有广东标识度的科技金融服务体系，促进"科技—产业—金融"良 性循环，重点是要围绕"四化"加强科技支行建设，即产品"特色化"、制度"差异化"、管理"体系化"和服 务"多元化"。 范乐宇指出，新质生产力发展对科技金融提出新的要求——除了引资，更要"引智"，赋能科技创新，加 速创新成果转化及创新效率提升。在此背景下，需要加快构建与新质生产力发展相适配的科技金融服务 新范式，其中，科技金融服务的体系化建设是重中之重。 一是做好存量政策的迭代升级和增量政策 ...

Core Viewpoint - The article highlights the significant achievements and ongoing reforms of the Sci-Tech Innovation Board (STAR Market) in China over the past six years, emphasizing its role in supporting hard technology enterprises and fostering innovation in the capital market. Group 1: Achievements of the STAR Market - As of July 22, 2025, the STAR Market has 589 listed companies, raising a total of 9,257 billion yuan through IPOs and 1,867 billion yuan through refinancing, totaling over 1.1 trillion yuan [2][5][22]. - The STAR Market has become a vibrant platform for hard technology companies, with over 379 companies recognized as national "specialized and innovative" small giants, and 65 companies designated as "single champion" enterprises in manufacturing [5][22]. - The compound annual growth rates for revenue and net profit attributable to shareholders of STAR Market companies from 2019 to 2024 are 19% and 9%, respectively [5]. Group 2: Institutional Innovations - The STAR Market has implemented a series of institutional innovations, including the "1+6" policy measures aimed at enhancing the capital market's support for technological innovation and new productivity development [3][18]. - The introduction of the "STAR Growth Tier" and related reforms marks a new phase of precise support for technology innovation enterprises [3]. - The STAR Market has established a multi-dimensional regulatory framework that enhances the development environment for technology innovation companies [6]. Group 3: R&D Investment and Innovation - In 2024, the total R&D investment of STAR Market companies reached 168 billion yuan, which is over three times the net profit of the board, with a median R&D intensity of 12.6% [11][29]. - Approximately 30% of STAR Market companies have products or projects that are industry-first, and over 380 companies have products or technologies that meet international advanced standards [32]. - The STAR Market has seen significant contributions to the pharmaceutical sector, with 19 out of 20 companies listed under the fifth set of standards having their self-developed drugs or vaccines approved for sale [6][26]. Group 4: Ecosystem and Talent Attraction - The STAR Market plays a crucial role in facilitating a virtuous cycle among technology, industry, and capital, with over 60% of its founding teams comprising scientists or industry experts [14]. - Nearly 90% of STAR Market companies received venture capital investment before going public, indicating a strong early-stage investment environment [14]. - The STAR Market has developed a comprehensive index system, with 29 indices tracking its performance, and products tracking the STAR Market indices totaling nearly 260 billion yuan [14]. Group 5: Investor Returns and Corporate Governance - In 2024, 509 companies on the STAR Market disclosed plans to enhance quality and efficiency, with over 60% proposing cash dividend plans totaling 38.8 billion yuan [15]. - The STAR Market has seen a record number of share buybacks and increases in shareholding, with 470 instances of buyback plans amounting to nearly 38 billion yuan [15].